Alasks settles Zyprexa case
Full Story
| News Archive
| Topics: legal, Medicaid, medication, pharmaceutical, Zyprexa
Eli Lilly has agreed to a $15 million settlement with Alaska over the drug Zyprexa, used a drug to treat schizohprenia and bipolar disorder. The settlement ended a jury trial which began March 6 in Anchorage Superior Court, in which Alaska asked for $270 million for the drug used in its Medicaid program. Reuters reports that Conn. brought a similar law suit on March 11. The company has paid out more than $1.2 billion to settle 30,000 individual law suits.
